CELLULAR BIOMEDICINE GROUP HK LTD has a total of 20 patent applications. Its first patent ever was published in 2013. It filed its patents most often in EPO (European Patent Office), Australia and Republic of Korea. Its main competitors in its focus markets biotechnology, pharmaceuticals and chemical engineering are JUNO THERAPEUTICS GMBH, ANHUI SINOBIOWAY CELL THERAPY CO LTD and REFUGE BIOTECHNOLOGIES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | Australia | 4 | |
#3 | Republic of Korea | 4 | |
#4 | Singapore | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Chemical engineering | |
#4 | Measurement | |
#5 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Separation | |
#6 | Microbiology | |
#7 | Analysing materials | |
#8 | Preservation of human bodies |
# | Name | Total Patents |
---|---|---|
#1 | Zhang Li | 16 |
#2 | Wei Yutian | 9 |
#3 | Zhu Shigui | 9 |
#4 | Huang Jiaqi | 9 |
#5 | Yao Xin | 9 |
#6 | Zhu Lin | 9 |
#7 | Yao Yihong | 9 |
#8 | Li Yanfeng | 9 |
#9 | Zhang Luyi | 8 |
#10 | Yan Ting | 7 |
Publication | Filing date | Title |
---|---|---|
AU2019241300A1 | Method for large-scale preparation of purified preparation of recombinant lentiviral vector at GMP grade | |
KR20200136463A | Large-scale manufacturing method of lentivirus using GMP-level serum-free suspension cells | |
AU2018423493A1 | Method for preparing chimeric antigen receptor T cells by serum-free culture | |
CN110372796A | The Chimeric antigen receptor and its preparation method of targeting BCMA and application | |
WO2013163959A1 | Long term preservation solution of adipose tissue for isolating and culturing stem cell |